Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
nourish lungs and strengthen spleen granules
- Development stage
- Unknown
- Lead developer
- Guangzhou University of Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Nourish Lungs and Strengthen Spleen Granules (Yangfei Jianpi Keli) is a Traditional Chinese Medicine (TCM) compound formulation primarily used for the treatment of respiratory diseases. It is specifically indicated for patients with Chronic Obstructive Pulmonary Disease (COPD) in the stable phase and for the recovery of patients during the convalescent stage of viral pneumonia, including COVID-19. The formula is based on the TCM principle of "tonifying the earth to generate gold" (strengthening the spleen to support the lungs). It typically contains a blend of herbs such as Astragalus, Codonopsis, and Atractylodes, which work synergistically to improve lung function, enhance immune response, and alleviate symptoms like cough, shortness of breath, and fatigue. Clinical studies have demonstrated its ability to reduce the frequency of acute exacerbations in COPD and improve the quality of life by modulating inflammatory markers and T-cell subsets.
- Brand names
- Yangfei Jianpi Keli
- Other names
- Yangfei Jianpi GranulesNourish Lungs and Strengthen Spleen Granules
02
Targets
IL-6 (Interleukin 6)IL8 (C-X-C Motif Chemokine Ligand 8)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on nourish lungs and strengthen spleen granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on nourish lungs and strengthen spleen granules.